Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.
- DOI
- 10.3389/fcell.2021.764481
- Published
- 2021
- Container
- Frontiers in cell and developmental biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcell.2021.764481,
title = {Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.},
author = {Li F and Shi Y and Yang X and Luo Z and Zhang G and Yu K and Li F and Chen L and Zhao Y and Xie Y and Wu Y and Yang J and Zhou X and Liu S},
year = {2021},
journal = {Frontiers in cell and developmental biology},
doi = {10.3389/fcell.2021.764481},
url = {https://doi.org/10.3389/fcell.2021.764481}
}RIS
TY - JOUR TI - Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis. AU - Li F AU - Shi Y AU - Yang X AU - Luo Z AU - Zhang G AU - Yu K AU - Li F AU - Chen L AU - Zhao Y AU - Xie Y AU - Wu Y AU - Yang J AU - Zhou X AU - Liu S PY - 2021 JO - Frontiers in cell and developmental biology DO - 10.3389/fcell.2021.764481 UR - https://doi.org/10.3389/fcell.2021.764481 ER -
APA
F, L., Y, S., X, Y., Z, L., G, Z., K, Y., F, L., L, C., Y, Z., Y, X., Y, W., J, Y., X, Z., & S, L. (2021). Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.. Frontiers in cell and developmental biology. https://doi.org/10.3389/fcell.2021.764481
Source records
- pubmed · retrieved 2026-09-25T00:09:00.288Z